Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran)
15 February 2024
| COVID-19: Vaccines

Overview
This training provides information on characteristics of different formulations of Pfizer-BioNTech COVID-19 vaccine, and procedures for effective management of the vaccine during storage, transport and use. It also includes guidance for establishing an ultra-cold chain system. It is recommended to select the appropriate slides/modules based on the training needs and profile of the participants.
The training slide set is organized in 16 modules:
- Module 1: Product overview: Pfizer-BioNTech COVID-19 vaccine/COMIRNATY®
- Module 2: Packaging and labeling information
- Module 3: Monitoring vaccine expiration date and shelf life
- Module 4: WHO guidance on off-label use of vaccines
- Module 5: Vaccination schedule based on WHO SAGE recommendations
- Module 6: Operational considerations on vaccine management and administration
- Module 7: Shipping and vaccine arrival procedures
- Module 8: Recommended vaccine deployment strategies
- Module 9: Orientation on thermal shipping containers
- Module 10: Orientation on temperature data loggers
- Module 11: Equipment options for storing vaccines at ultra-low temperature
- Module 12: Orientation on Ultra-low temperature (ULT) freezers and selection criteria
- Module 13: Ultra-cold chain (UCC) system readiness
- Module 14: Options for transporting ULT frozen vaccines to subnational stores
- Module 15: Options for transporting and storing vaccines at lower-level stores and service points
- Module 16: Managing vaccine storage and transport at service points
This material has been updated in all languages: version 15 February 2024.
First publication date 4 August 2021. Updated on 15 April 2022, 7 July 2022, 3 October 2022, 23 December 2022, 20 January 2023, 7 February 2023, August 2023, and September 2023.
Latest update: 15 February 2024
WHO Team
COVAX
Number of pages
139